top of page

In Memoriam

We mourn passing of Dr. Waseem Malick, our friend, advisor and mentor 

We remember our friend, mentor, and advisor Dr. Waseem Malick and mourn his passing. Dr. Malick was the first person to join our advisory board, and was a tireless advocate and supporter of our company. He eagerly attended every presentation and never stopped encouraging us. We will never forget his infectious enthusiasm every time we shared research and achieved a milestone.

Prior to joining the science advisory of SMDG, Dr. Malick was the Senior Vice President, Pharmaceutical & Analytical R&D at Hoffmann-La Roche and led Roche, Nutley, New Jersey site. He worked at Roche for over 30 years and created and led a world-class global R&D teams recognized for innovative drug products. His team successfully developed, registered and supported launch of several innovative medicines (e.g., Zelboraf®, Xeloda®, Roferon®, Zenapax®, Fuzeon®, Saquinavir®, Pegasys®, Copegus®, Versed®, Accutane®). He and his team led technical development from discovery phase (Clinical Lead Optimization) to late stage (NDA).  Dr. Malick was recognized for his exceptional management and leading scientific personnel in multiple global centers, strategic planning, multimillion dollar investments, operating & capital budgets. In addition, he served on technical committees with review and oversight responsibilities of all internal as well as due-diligence licensing-in projects ensuring technical success. Dr. Malick also served on Board of Directors of non-profit organizations, Scientific Board of universities and held academic appointments. Most notably he served on the Research & Development Council of New Jersey, a nonprofit organization which advocates for progress in various research and development sectors in the state of New Jersey.  Dr. Malick was also a great advocate for STEM education and served as advisor and speaker to a number of organizations.

We have lost a dear friend who will be greatly missed.  Our condolences to his family, friends and colleagues.

bottom of page